At least 145 people have died of Tuberculosis (TB) in Mizoram in 2025, the highest fatalities in six years since 2020, state health department said. According to the record of National TB elimination programme under the national health mission Mizoram, a total of 2,275 people, including 911 females, were diagnosed with the disease during the same year, a small margin decrease from the previous year (2024)’s record of 2,291 cases. Of the 2,275 new cases, 1,900 were detected in government facilities, while the remaining 375 cases were found in private facilities, it said. Altogether 145 people have succumbed to TB during 2025, which is the highest in six years since 2020, the data said. Although Mizoram experienced a dip and growth in new TB cases over the past six years, fatality has continuously increased since 2020, officials said. While 31 people died of TB in 2020, the number of fatalities increased to 46 in 2021, 87 in 2022, 119 in 2023 and 136 in 2024, they said. Of 2,275 new cases found in 2025, 146 people were diagnosed with multi-drug-resistant tuberculosis (MDR-TB) and 267 others were found suffering from both TB and HIV-positive, the data said. 2,134 newly diagnosed patients were above 14 years and 141were below 14 years, it said. Altogether 84 per cent of the patients have been successfully treated, the data said. Aizawl district recorded the highest cases at 1,569, followed by Lunglei district (155) and Kolasib district bordering Assam reported 138 cases during the same year, it said. Serchhip district reported the lease at 52 cases, it said. Officials also said that more than 100 people have registered to adopt TB patients or donate for them through the online platform “Nikshay” under the Pradhan Mantri TB Mukt Bharat Abhiyan. The Pradhan Mantri TB Mukt Bharat Abhiyan was launched nationwide by President Droupadi Murmu in September 2022. It is a community programme to augment community involvement in meeting India’s commitment to end TB by 2025 ahead of the global target of 2030, to provide additional patient support to improve treatment outcomes of TB patients and to leverage Corporate Social Responsibility (CSR) activities.
